Review
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. May 7, 2006; 12(17): 2730-2736
Published online May 7, 2006. doi: 10.3748/wjg.v12.i17.2730
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Sustained virological response rates in chronic hepatitis C naïve patients infected by genotype 1: studies with IFN-β administered intravenously. 1: Kainuma et al[16]. 2: Fukutomi et al[17]. 3: Kurosaki et al[18]. 4: Chemello et al[19]. 5: Kaito et al[20]. 6: Shiratori et al[21]. 7: Mochizuki et al[22]. 8: Kakizaki et al[23]. 9: Suzuki et al[24]. 10: Enomoto et al[25]. T: total [mean of studies].
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Sustained virological response rates in chronic hepatitis C genotype 1 naïve patients: studies with subcutaneous IFN-β. 1: Habersetzer et al[26]. 2: Andrade et al[27]. 3: Castro et al[28]. 4: Castro et al[29]. 5: Villa et al[30]. 6: Kakumu et al[31]. 7: Perez et al[32]. 8: Bernardinello et al[33]. 9: Frosi et al[34]. 10: Pellicano et al[35]. 11: Nakamura et al[36]. 12: Fesce et al[12]. T: total [mean of studies].
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Sustained virological response rates in chronic hepatitis C naïve patients infected by genotype no-1: studies with intravenous IFN-β. 1: Fukutomi et al[17]. 2: Kurosaki et al[18]. 3: Shiratori et al[21]. 4: Nakamura et al[37]. 5: Mochizuki et al[22]. 6: Kakizaki et al[23]. T: total [mean of studies].